Envista Holdings develops and markets dental products and equipment spanning implants, orthodontics, imaging, and treatment instruments. Its portfolio includes well-known professional brands such as Nobel Biocare, Ormco, and KaVo Kerr, used by dentists, specialists, and laboratories worldwide. The company focuses on clinically driven technologies and consumables that support restorative, orthodontic, and diagnostic workflows in dental practices.
| Quarter | Revenue | YoY % | Earnings | YoY % |
|---|---|---|---|---|
| Q2 2025 | 682.1 | — | 26.4 | — |
| Q3 2025 | 669.9 | — | -30.3 | — |
| Q4 2025 | 750.6 | — | 32.9 | — |
| Q1 2026 | 705.5 | — | 38.7 | — |
| Q2 2026 | 730.5 | 7.1% | 53.7 | 103.4% |
All markets — KeepWinning global stock screener
Other companies on NYSE: Badger Meter, Inc. (BMI), Twenty One Capital, Inc. (XXI), Renasant Corporation (RNST), Atmus Filtration Technologies Inc. (ATMU), GPGI, Inc. (GPGI), Organon & Co. (OGN)